Cargando…
MET exon 14 skipping defines a unique molecular class of non-small cell lung cancer
PURPOSE: Recurrent MET exon 14 splicing has been revealed in lung cancers and is a promising therapeutic target. Because we have limited knowledge about the natural history of MET mutant tumors, the current study was aiming to determine the clinical and pathological characteristics in non-small cell...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173088/ https://www.ncbi.nlm.nih.gov/pubmed/27223439 http://dx.doi.org/10.18632/oncotarget.9541 |